
|Videos|November 16, 2022
Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Two-Drug HIV Regimens, Archived M184V Resistance, and Long-Acting Preference
2
SNO 2026 Roundup: What Longer Follow-Up Means for Targeted Glioma Care
3
Overton FDA Nomination Withdrawn: What It Means for Pharmacists
4
Long-Acting HIV Injectables in Viremia and New Tenofovir-Free Oral Options
5

